Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

被引：0
|
作者：
Schmidt, MK
van Sprundel, TC
Rookus, MA
Brohet, R
van Asperen, CJ
Rutgers, EJT
Tollenaar, RAEM
van't Veer, LJ
机构：
[1] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands
[4] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands
来源：
BREAST CANCER RESEARCH | 2005年 / 7卷 / Suppl 2期
关键词：
Breast Cancer; Contralateral Breast Cancer; BRCA2 Mutation Carrier; Mutation Testing; Contralateral Prophylactic Mastectomy;
D O I：
10.1186/bcr1096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [31] Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer, H
    van Geel, B
    van Putten, WLJ
    Henzen-Logmans, SC
    Seynaeve, C
    Menke-Pluymers, MBE
    Bartels, CCM
    Verhoog, LC
    van den Ouweland, AMW
    Niermeijer, MF
    Brekelmans, CTM
    Klijn, JGM
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03): : 159 - 164
  • [32] Screening and clinical implications for BRCA1 and BRCA2 mutation carriers
    Plon, SE
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (04) : 377 - 387
  • [33] Screening and Clinical Implications for BRCA1 and BRCA2 Mutation Carriers
    Sharon E. Plon
    Journal of Mammary Gland Biology and Neoplasia, 1998, 3 : 377 - 387
  • [34] Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
    Metcalfe, Kelly
    Gershman, Shelley
    Ghadirian, Parviz
    Lynch, Henry T.
    Snyder, Carrie
    Tung, Nadine
    Kim-Sing, Charmaine
    Eisen, Andrea
    Foulkes, William D.
    Rosen, Barry
    Sun, Ping
    Narod, Steven A.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [35] Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Phillips, Kelly-Anne
    Milne, Roger L.
    Rookus, Matti A.
    Daly, Mary B.
    Antoniou, Antonis C.
    Peock, Susan
    Frost, Debra
    Easton, Douglas F.
    Ellis, Steve
    Friedlander, Michael L.
    Buys, Saundra S.
    Andrieu, Nadine
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Bonadona, Valerie
    Pujol, Pascal
    McLachlan, Sue Anne
    John, Esther M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    Tollenaar, Rob A. E. M.
    Goldgar, David E.
    Terry, Mary Beth
    Caldes, Trinidad
    Weideman, Prue C.
    Andrulis, Irene L.
    Singer, Christian F.
    Birch, Kate
    Simard, Jacques
    Southey, Melissa C.
    Olsson, Hakan L.
    Jakubowska, Anna
    Olah, Edith
    Gerdes, Anne-Marie
    Foretova, Lenka
    Hopper, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3091 - 3099
  • [36] Increased risk of contralateral breast cancer for BRCA1 mutation carriers compared to BRCA2 mutation carriers
    Graeser, M.
    Engel, C.
    Zaino, M.
    Schmutzler, R.
    ONKOLOGIE, 2008, 31 : 28 - 28
  • [37] Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
    Rebbeck, TR
    Lynch, HT
    Neuhausen, SL
    Narod, SA
    van't Veer, L
    Garber, JE
    Evans, G
    Isaacs, C
    Daly, MB
    Matloff, E
    Olopade, OI
    Weber, BL
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21): : 1616 - 1622
  • [38] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [39] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [40] Prevalence of high-risk lesions in prophylactic mastectomy specimens of 82 BRCA1 and BRCA2 mutation carriers
    Hoogerbrugge, N.
    Bult, P.
    Ligtenberg, M. J. L.
    Bonenkamp, J. J.
    de Hullu, J. A.
    Niermeijer, M. F.
    Brunner, H. G.
    EJC SUPPLEMENTS, 2005, 3 (02): : 65 - 65
12345